欧州連合 - 英語 - EMA (European Medicines Agency)

janssen cilag international nv - selexipag - hypertension, pulmonary - antithrombotic agents - uptravi is indicated for the long-term treatment of pulmonary arterial hypertension (pah) in adult patients with who functional class (fc) ii–iii, either as combination therapy in patients insufficiently controlled with an endothelin receptor antagonist (era) and/or a phosphodiesterase type 5 (pde-5) inhibitor, or as monotherapy in patients who are not candidates for these therapies. efficacy has been shown in a pah population including idiopathic and heritable pah, pah associated with connective tissue disorders, and pah associated with corrected simple congenital heart disease.,

マルタ - 英語 - Malta Medicines Authority

janssen-cilag international nv turnhoutseweg 30, b-2340 beerse, belgium - galantamine - film-coated tablet - galantamine - psychoanaleptics

マルタ - 英語 - Malta Medicines Authority

janssen-cilag international nv turnhoutseweg 30, b-2340 beerse, belgium - galantamine - film-coated tablet - galantamine - psychoanaleptics

マルタ - 英語 - Malta Medicines Authority

janssen-cilag international nv turnhoutseweg 30, b-2340 beerse, belgium - galantamine - film-coated tablet - galantamine - psychoanaleptics

マルタ - 英語 - Malta Medicines Authority

janssen-cilag international nv turnhoutseweg 30, b-2340 beerse, belgium - norgestimate, ethinylestradiol - tablet - norgestimate 250 µg ethinylestradiol 35 µg - sex hormones and modulators of the genital system

ジンバブエ - 英語 - Medicines Control Authority

janssen-cilag international nv - darunavir - tablet, coated; oral - 150mg

ジンバブエ - 英語 - Medicines Control Authority

janssen-cilag international nv - bedaquiline - tablet; oral - 100mg

オーストラリア - 英語 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

janssen pharmaceutica n.v. - imazalil present as imazalil sulphate; pyrimethanil - suspension concentrate - imazalil present as imazalil sulphate imidazole active 200.0 g/l; pyrimethanil pyrimidine active 200.0 g/l - fungicide - citrus | grapefruit | lemon | lime | mandarin | orange - blue and green moulds

欧州連合 - 英語 - EMA (European Medicines Agency)

janssen-cilag international nv - ciltacabtagene autoleucel - multiple myeloma - carvykti is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

欧州連合 - 英語 - EMA (European Medicines Agency)

janssen-cilag international nv - etravirine - hiv infections - non-nucleoside reverse transcriptase inhibitors, antivirals for systemic use - intelence, in combination with a boosted protease inhibitor and other antiretroviral medicinal products, is indicated for the treatment of human-immunodeficiency-virus-type-1 (hiv-1) infection in antiretroviral-treatment-experienced adult patients and in antiretroviral-treatment-experienced paediatric patients from six years of age.this indication is based on week-48 analyses from two phase-iii trials in highly pretreated patients where intelence was investigated in combination with an optimised background regimen (obr) which included darunavir/ritonavir. the indication in paediatric patients is based on 48-week analyses of a single-arm, phase-ii trial in antiretroviral-treatment-experienced paediatric patients.